tradingkey.logo
搜尋

West Pharmaceutical Services Inc

WST
添加自選
328.200USD
-27.480-7.73%
收盤 07-24 16:00美東報價延遲15分鐘
23.63B總市值
43.66本益比TTM

West Pharmaceutical Services Inc

328.200
-27.480-7.73%

關於 West Pharmaceutical Services Inc 公司

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

West Pharmaceutical Services Inc簡介

公司代碼WST
公司名稱West Pharmaceutical Services Inc
上市日期Sep 01, 2059
CEOGreen (Eric Mark)
員工數量10600
證券類型Ordinary Share
年結日Sep 01
公司地址530 Herman O. West Drive
城市EXTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編19341
電話16105942900
網址https://www.westpharma.com/
公司代碼WST
上市日期Sep 01, 2059
CEOGreen (Eric Mark)

West Pharmaceutical Services Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
--
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.36K
+4.09%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.78K
+7.34%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
4.44K
+17.82%
Mr. Shane Campbell
Mr. Shane Campbell
Senior Vice President, Chief Proprietary Segment Officer
Senior Vice President, Chief Proprietary Segment Officer
3.67K
+15.01%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
3.52K
+22.45%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
--
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.36K
+4.09%

常見問題

West Pharmaceutical Services Inc的前五大股東是誰?

West Pharmaceutical Services Inc的前五大股東如下:Mr. Eric Mark Green

哪個業務部門對West Pharmaceutical Services Inc的收入貢獻最大?

在2026Q4,High Value Components業務部門對West Pharmaceutical Services Inc的收入貢獻最大,創收1.44B,占總收入的47.00% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有